The charts on this page feature a breakdown of the total annual pay for the top executives at PUMA BIOTECHNOLOGY, INC. as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. PUMA BIOTECHNOLOGY, INC. income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. PUMA BIOTECHNOLOGY, INC. annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Alan H. Auerbach
President and Chief Executive Officer
Total Cash $1,286,964 Equity $2,455,226 Other $13,132 Total Compensation $3,755,322
Richard P. Bryce MBChB, MRC
Senior Vice President, Clinical Research and Development
Total Cash $704,105 Equity $610,838 Other $16,196 Total Compensation $1,331,139
Steven Lo
Chief Commercial Officer
Total Cash $468,507 Equity $792,034 Other $57,438 Total Compensation $1,317,979
Maximo F. Nougues
Chief Financial Officer
Total Cash $652,667 Equity $0 Other $13,132 Total Compensation $665,799
Douglas Hunt B.Sc (Hons).
Senior Vice President, Regulatory Affairs, Medical Writing and Project Management
Total Cash $511,869 Equity $854,558 Other $11,960 Total Compensation $1,378,387
For its 2019 fiscal year, PUMA BIOTECHNOLOGY, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC.
CEO Name CEO Pay Median Employee Pay CEO Pay Ratio
Alan H. Auerbach CEO Pay $3,755,322 Median Employee Pay $280,430 CEO Pay Ratio 13:1
For its 2019 fiscal year, PUMA BIOTECHNOLOGY, INC., listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Adrian M. Senderowicz Total Cash $337,201
Ann C. Miller Total Cash $834,573
Frank E. Zavrl Total Cash $345,951
Hugh O'Dowd Total Cash $461,937
Jay M. Moyes Total Cash $357,201
Michael P. Miller Total Cash $327,201
Troy E. Wilson Total Cash $342,201

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.